Loading...
Tamoxifen
India Pharmaceutical Trade Intelligence
Who Supplies Tamoxifen to India from UNITED STATES
India's tamoxifen imports from UNITED STATES total $2.0M across 13 shipments from 3 foreign suppliers. ACTAVIS LABORATORIES FL INC. leads with $1.9M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for tamoxifen — a concentrated sourcing relationship with select suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
ACTAVIS LABORATORIES FL INC. is the leading Tamoxifen supplier from UNITED STATES to India, with import value of $1.9M across 7 shipments. The top 5 suppliers — ACTAVIS LABORATORIES FL INC., ACTAVIS LABORATORIES FL INC, REGIONAL PHARMACY — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS LABORATORIES FL INC. | $1.9M | 7 | 96.3% |
| 2 | ACTAVIS LABORATORIES FL INC | $73.4K | 4 | 3.7% |
| 3 | REGIONAL PHARMACY | $611 | 2 | 0.0% |
Showing top 3 of 3 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $2.0M | 11 | 100.0% |
| 2 | EUGIA PHARMA SPECIALITIES LIMITED | $611 | 2 | 0.0% |
Import Statistics
- Import Value
- $2.0M
- Shipments
- 13
- Foreign Suppliers
- 3
- Indian Buyers
- 2
- Avg. Shipment
- $153.2K
Other Tamoxifen Import Origins
Related Analysis
Frequently Asked Questions — Tamoxifen Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Tamoxifen suppliers from UNITED STATES to India?
The top Tamoxifen suppliers from UNITED STATES to India include ACTAVIS LABORATORIES FL INC., ACTAVIS LABORATORIES FL INC, REGIONAL PHARMACY. The leading supplier is ACTAVIS LABORATORIES FL INC. with import value of $1.9M USD across 7 shipments. India imported Tamoxifen worth $2.0M USD from UNITED STATES in total across 13 shipments.
QHow much Tamoxifen does India import from UNITED STATES?
India imported Tamoxifen worth $2.0M USD from UNITED STATES across 13 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Tamoxifen from UNITED STATES?
The main Indian buyers of Tamoxifen sourced from UNITED STATES include ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED, EUGIA PHARMA SPECIALITIES LIMITED. The largest buyer is ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED with $2.0M in imports across 11 shipments.
QWhat is the total value of Tamoxifen imports from UNITED STATES to India?
The total value of Tamoxifen imports from UNITED STATES to India is $2.0M USD, across 13 shipments and 3 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Tamoxifen.
- 2.Supplier/Buyer Matching: 3 foreign suppliers from UNITED STATES and 2 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $2.0M aggregated from 13 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13 Verified Shipments
3 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists